Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Erythropoietin.

G R Johnson

    British Medical Bulletin
    |April 1, 1989
    PubMed
    Summary
    This summary is machine-generated.

    Erythropoietin, a hormone primarily produced by the kidneys, can be synthesized as recombinant erythropoietin. This therapy effectively increases red blood cell production in patients with anemia, reducing transfusion needs.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Retraction Note: Dynamin 2 mediates PDGFRα-SHP-2-promoted glioblastoma growth and invasion.

    Oncogene·2025
    Same author

    Quantifying the effectiveness of ultraviolet-C light at inactivating airborne Mycobacterium abscessus.

    The Journal of hospital infection·2022
    Same author

    Investigating surface binding effects: antibacterial efficacy of bound 8-hydroxyquinoline against Staphylococcus aureus and Escherichia coli.

    Journal of applied microbiology·2021
    Same author

    Characterization of expiration air jets and droplet size distributions immediately at the mouth opening.

    Journal of aerosol science·2020
    Same author

    Thermionic Cooling of the Target Plasma to a Sub-eV Temperature.

    Physical review letters·2019
    Same author

    First Report of Swiss Needle Cast Caused by Phaeocryptopus gaeumannii on Douglas-Fir in Turkey.

    Plant disease·2019
    Same journal

    Human health in relation to visible, functional, and accessible green space: a systematic review and narrative synthesis of the 3 + 30 + 300 guideline.

    British medical bulletin·2026
    Same journal

    Muscle herniae in exercise-induced leg pain: diagnostic pitfalls and the 'repair paradox'.

    British medical bulletin·2026
    Same journal

    Scaffolds and platelet concentrates in bone regenerative medicine: applications, mechanisms, and future approaches.

    British medical bulletin·2026
    Same journal

    Back squat and deadlift fatiguing protocols elicit distinct countermovement jump profiles: phase-specific predictors and soreness responses.

    British medical bulletin·2026
    Same journal

    Enhancing bone healing through osteogenic medium components: biological roles, mechanisms, and clinical applications.

    British medical bulletin·2026
    Same journal

    Moral injury in healthcare workers: causes & interventions.

    British medical bulletin·2026
    See all related articles

    Area of Science:

    • Endocrinology
    • Molecular Biology
    • Genetics

    Background:

    • Erythropoietin (EPO) is a key hormone regulating red blood cell production.
    • Kidney peritubular cells are the primary source of EPO in adults, responding to hypoxic conditions.
    • EPO's biological activity can be assessed through various in vivo and in vitro assays.

    Purpose of the Study:

    • To describe the characteristics of erythropoietin, including its gene location and protein structure.
    • To evaluate the therapeutic potential of recombinant erythropoietin in treating erythropoiesis disorders.

    Main Methods:

    • Analysis of erythropoietin gene conservation and chromosomal location (human chromosome 7q11-q22).
    • Characterization of the mature erythropoietin hormone (166 amino acids, ~50% carbohydrate, Mr 39,000).

    Related Experiment Videos

  • Clinical administration of recombinant erythropoietin to patients undergoing haemodialysis.

    • Main Results:

    • Recombinant erythropoietin administration led to increased hemoglobin, reticulocyte counts, and hematocrit.
    • Transfusion-dependent patients showed a reduced need for regular transfusions.
    • Hypertension was noted in some patients, particularly those with pre-existing hypertension.

    Conclusions:

    • Recombinant erythropoietin demonstrates significant efficacy in correcting anemia and reducing transfusion requirements.
    • It offers a promising alternative therapy for disorders of erythropoiesis, despite potential side effects like hypertension.